These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 18329699

  • 1. Large-scale preparation of thrombin from human plasma.
    Aizawa P, Winge S, Karlsson G.
    Thromb Res; 2008; 122(4):560-7. PubMed ID: 18329699
    [Abstract] [Full Text] [Related]

  • 2. Inactivation and clearance of viruses during the manufacture of high purity factor IX.
    Johnston A, Macgregor A, Borovec S, Hattarki M, Stuckly K, Anderson D, Goss NH, Oates A, Uren E.
    Biologicals; 2000 Sep; 28(3):129-36. PubMed ID: 10964439
    [Abstract] [Full Text] [Related]

  • 3. Human coagulation factor IX: assessment of thrombogenicity in animal models and viral safety.
    Herring SW, Abildgaard C, Shitanishi KT, Harrison J, Gendler S, Heldebrant CM.
    J Lab Clin Med; 1993 Mar; 121(3):394-405. PubMed ID: 8445288
    [Abstract] [Full Text] [Related]

  • 4. A simplified procedure for purification of human prothrombin, factor IX and factor X.
    Bajaj SP, Rapaport SI, Prodanos C.
    Prep Biochem; 1981 Mar; 11(4):397-412. PubMed ID: 7312833
    [Abstract] [Full Text] [Related]

  • 5. Human coagluation factor V purification and thrombin-catalyzed activation.
    Dahlbäck B.
    J Clin Invest; 1980 Sep; 66(3):583-91. PubMed ID: 7400329
    [Abstract] [Full Text] [Related]

  • 6. A procedure for isolation of human protein C and protein S as by-products of the purification of factors VII, IX, X and prothrombin.
    Bajaj SP, Rapaport SI, Maki SL, Brown SF.
    Prep Biochem; 1983 Sep; 13(3):191-214. PubMed ID: 6226944
    [Abstract] [Full Text] [Related]

  • 7. Pilot production of recombinant human clotting factor IX from transgenic sow milk.
    Sun YL, Chang YS, Lin YS, Yen CH.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jun 01; 898():78-89. PubMed ID: 22578515
    [Abstract] [Full Text] [Related]

  • 8. Homologous human blood protein separation using immobilized metal affinity chromatography: protein C separation from prothrombin with application to the separation of factor IX and prothrombin.
    Wu H, Bruley DF.
    Biotechnol Prog; 1999 Jun 01; 15(5):928-31. PubMed ID: 10514264
    [Abstract] [Full Text] [Related]

  • 9. Immobilized hirudin and hirudin-based peptides used for the purification of recombinant human thrombin prepared from recombinant human prothrombin.
    Fischer BE, Mitterer A, Schlokat U, Grillberger L, Reiter M, Mundt W, Dorner F, Eibl J.
    Protein Expr Purif; 1996 Sep 01; 8(2):167-74. PubMed ID: 8812854
    [Abstract] [Full Text] [Related]

  • 10. Purification of alpha 1 proteinase inhibitor from human plasma fraction IV-1 by ion exchange chromatography.
    Chen SX, Hammond DJ, Lang JM, Lebing WR.
    Vox Sang; 1998 Sep 01; 74(4):232-41. PubMed ID: 9691404
    [Abstract] [Full Text] [Related]

  • 11. In vitro study of a triple-secured von Willebrand factor concentrate.
    Mazurier C, Poulle M, Samor B, Hilbert L, Chtourou S.
    Vox Sang; 2004 Feb 01; 86(2):100-4. PubMed ID: 15023178
    [Abstract] [Full Text] [Related]

  • 12. A highly efficient integrated chromatographic procedure for the purification of recombinant hepatitis B surface antigen from Hansenula polymorpha.
    Huang Y, Bi J, Zhang Y, Zhou W, Li Y, Zhao L, Su Z.
    Protein Expr Purif; 2007 Dec 01; 56(2):301-10. PubMed ID: 17910922
    [Abstract] [Full Text] [Related]

  • 13. Preparation of recombinant alpha-thrombin: high-level expression of recombinant human prethrombin-2 and its activation by recombinant ecarin.
    Yonemura H, Imamura T, Soejima K, Nakahara Y, Morikawa W, Ushio Y, Kamachi Y, Nakatake H, Sugawara K, Nakagaki T, Nozaki C.
    J Biochem; 2004 May 01; 135(5):577-82. PubMed ID: 15173195
    [Abstract] [Full Text] [Related]

  • 14. A solvent/detergent-treated and 15-nm filtered factor VIII: a new safety standard for plasma-derived coagulation factor concentrates.
    Chtourou S, Porte P, Nogré M, Bihoreau N, Cheesman E, Samor B, Sauger A, Raut S, Mazurier C.
    Vox Sang; 2007 May 01; 92(4):327-37. PubMed ID: 17456157
    [Abstract] [Full Text] [Related]

  • 15. [Blood protein technological industrial developments as a mirror of fundamental studies bgy the Institute of Biochemistry of the Ukrainian National Academy of Sciences].
    Volkov GL, Andrianov SI, Horoshnykova TV, Borysevych OS, Gavryliuk OS.
    Ukr Biokhim Zh (1999); 2000 May 01; 72(4-5):109-21. PubMed ID: 11200439
    [Abstract] [Full Text] [Related]

  • 16. Isolation and characterization of mouse coagulation factor X -- biophysical and enzymological properties.
    James HL, Larson PJ, Chao YB, Yan SB, Kim DJ.
    Thromb Haemost; 1997 Sep 01; 78(3):1049-54. PubMed ID: 9308752
    [Abstract] [Full Text] [Related]

  • 17. Chromatographic preparation and in vitro properties of albumin from human plasma.
    Berglöf JH, Eriksson S, Curling JM.
    J Appl Biochem; 1983 Sep 01; 5(4-5):282-92. PubMed ID: 6679542
    [Abstract] [Full Text] [Related]

  • 18. [High purification of human thrombin].
    Zhong J, Yin W, Lin Y, Liu Y, Lu S.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Feb 01; 17(1):36-40. PubMed ID: 7781126
    [Abstract] [Full Text] [Related]

  • 19. A rapid simplified purification of bovine thrombin.
    Ding Z, Xu Y.
    Prep Biochem; 1995 Feb 01; 25(1-2):21-8. PubMed ID: 7603970
    [Abstract] [Full Text] [Related]

  • 20. Properties of a highly purified human plasma factor IX:c therapeutic concentrate prepared by conventional chromatography.
    Burnouf T, Michalski C, Goudemand M, Huart JJ.
    Vox Sang; 1989 Feb 01; 57(4):225-32. PubMed ID: 2617959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.